{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:53:34Z","timestamp":1792511614921,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106333","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T22:09:51Z","timestamp":1656540591000},"page":"106333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy"],"prefix":"10.1016","volume":"182","author":[{"given":"Cheng","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2022.106333_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamaoncol.2015.1198","article-title":"Changing treatment paradigms in metastatic breast cancer: lessons learned","volume":"1","author":"Santa-Maria","year":"2015","journal-title":"JAMA Oncol."},{"issue":"10087","key":"10.1016\/j.phrs.2022.106333_bib3","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.phrs.2022.106333_bib4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Disco"},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2022.106333_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator pfkfb3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.phrs.2022.106333_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med"},{"issue":"6249","key":"10.1016\/j.phrs.2022.106333_bib9","first-page":"694","article-title":"Cancer","volume":"349","author":"Rivera","year":"2015","journal-title":"Tumor angiogenesis, foe Friend, Sci."},{"issue":"5706","key":"10.1016\/j.phrs.2022.106333_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.phrs.2022.106333_bib11","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.apsb.2020.09.014","article-title":"Manipulation of immunevascular crosstalk: new strategies towards cancer treatment","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.phrs.2022.106333_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ccr.2014.06.025","article-title":"Tumor vessel normalization by chloroquine independent of autophagy","volume":"26","author":"Maes","year":"2014","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2022.106333_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","article-title":"Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming","volume":"23","author":"Tiwari","year":"2013","journal-title":"Cancer Cell"},{"issue":"7842","key":"10.1016\/j.phrs.2022.106333_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","article-title":"Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis","volume":"589","author":"Pastushenko","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phrs.2022.106333_bib17","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41418-020-00615-9","article-title":"Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis","volume":"27","author":"Li","year":"2020","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.phrs.2022.106333_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41392-021-00741-x","article-title":"Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.phrs.2022.106333_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1039\/c0np00035c","article-title":"Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents","volume":"28","author":"Dong","year":"2011","journal-title":"Nat. Prod. Rep."},{"issue":"14","key":"10.1016\/j.phrs.2022.106333_bib21","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.7150\/thno.53170","article-title":"Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2022.106333_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7037786","article-title":"Targeting the Ang2\/Tie2 axis with tanshinone IIA elicits vascular normalization in ischemic injury and colon cancer","volume":"2021","author":"Zou","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"11","key":"10.1016\/j.phrs.2022.106333_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.phymed.2014.05.001","article-title":"Phenolcarboxylic acids from medicinal herbs exert anticancer effects through disruption of COX-2 activity","volume":"21","author":"Tao","year":"2014","journal-title":"Phytomedicine"},{"issue":"22","key":"10.1016\/j.phrs.2022.106333_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225653","article-title":"Salvianolic acid B slows the progression of breast cancer cell growth via enhancement of apoptosis and reduction of oxidative stress, inflammation, and angiogenesis","volume":"20","author":"Katary","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2022.106333_bib25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.biopha.2018.08.113","article-title":"Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction","volume":"107","author":"Chen","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2022.106333_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.colsurfb.2016.07.053","article-title":"Cellular uptake and anticancer activity of salvianolic acid B phospholipid complex loaded nanoparticles in head and neck cancer and precancer cells","volume":"147","author":"Li","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.phrs.2022.106333_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4908328","article-title":"Polypharmacological profiles underlying the antitumor property of salvia miltiorrhiza root (danshen) interfering with NOX-dependent neutrophil extracellular traps","volume":"2018","author":"Tao","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"issue":"6","key":"10.1016\/j.phrs.2022.106333_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41419-018-0623-9","article-title":"Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K\/AKT\/HIF-1alpha signaling pathway","volume":"9","author":"Wei","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.phrs.2022.106333_bib29","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.apsb.2019.12.011","article-title":"Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics","volume":"10","author":"Zhong","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2022.106333_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.09.026","article-title":"The VE-Cadherin\/beta-catenin signalling axis regulates immune cell infiltration into tumours","volume":"496","author":"Zhao","year":"2021","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/0008-5472.CAN-19-3351","article-title":"Beyond angiogenesis: exploiting angiocrine factors to restrict tumor progression and metastasis","volume":"80","author":"Singhal","year":"2020","journal-title":"Cancer Res."},{"issue":"385","key":"10.1016\/j.phrs.2022.106333_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci. Transl. Med"},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Disco"},{"issue":"7615","key":"10.1016\/j.phrs.2022.106333_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature19076","article-title":"Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis","volume":"536","author":"Strilic","year":"2016","journal-title":"Nature"},{"issue":"7828","key":"10.1016\/j.phrs.2022.106333_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-020-2774-y","article-title":"Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis","volume":"586","author":"Tavora","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","article-title":"Integrin alphavbeta6-TGFbeta-SOX4 pathway drives immune evasion in triple-negative breast cancer","volume":"39","author":"Bagati","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10565-018-09458-0","article-title":"Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells","volume":"35","author":"Jiang","year":"2019","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","article-title":"VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity","volume":"26","author":"Giannotta","year":"2013","journal-title":"Dev. Cell"},{"issue":"16","key":"10.1016\/j.phrs.2022.106333_bib41","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1158\/0008-5472.CAN-16-3129","article-title":"Targeting vascular endothelial-cadherin in tumor-associated blood vessels promotes t-cell-mediated immunotherapy","volume":"77","author":"Zhao","year":"2017","journal-title":"Cancer Res"},{"issue":"52","key":"10.1016\/j.phrs.2022.106333_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904997","article-title":"Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib43","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/s41467-019-12771-9","article-title":"Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin."},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib45","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1038\/s41467-021-26697-8","article-title":"Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization","volume":"12","author":"Xu","year":"2021","journal-title":"Nat. Commun."},{"issue":"7380","key":"10.1016\/j.phrs.2022.106333_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature10661","article-title":"A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells","volume":"481","author":"Png","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib47","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","article-title":"Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8-dependent melanoma metastasis and angiogenesis","volume":"151","author":"Pencheva","year":"2012","journal-title":"Cell"},{"issue":"7586","key":"10.1016\/j.phrs.2022.106333_bib48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature17040","article-title":"Angiocrine functions of organ-specific endothelial cells","volume":"529","author":"Rafii","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2022.106333_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cell.2011.10.003","article-title":"Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization","volume":"147","author":"Ding","year":"2011","journal-title":"Cell"},{"issue":"7321","key":"10.1016\/j.phrs.2022.106333_bib50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature09493","article-title":"Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration","volume":"468","author":"Ding","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib51","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.phrs.2022.106333_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat. Rev. Drug Disco"},{"issue":"10","key":"10.1016\/j.phrs.2022.106333_bib53","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.7150\/ijbs.37467","article-title":"Salvianolic acid A & B: potential cytotoxic polyphenols in battle against cancer via targeting multiple signaling pathways","volume":"15","author":"Qin","year":"2019","journal-title":"Int J. Biol. Sci."},{"issue":"19","key":"10.1016\/j.phrs.2022.106333_bib54","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7427","key":"10.1016\/j.phrs.2022.106333_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.phrs.2022.106333_bib56","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106333_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: First Approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib58","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s43018-021-00185-w","article-title":"EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer","volume":"2","author":"Morel","year":"2021","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2022.106333_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2006.02.018","article-title":"The VEGF-C\/Flt-4 axis promotes invasion and metastasis of cancer cells","volume":"9","author":"Su","year":"2006","journal-title":"Cancer Cell"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2022.106333_bib60","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10555-012-9387-3","article-title":"EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis","volume":"31","author":"Crea","year":"2012","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2022.106333_bib61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106333_bib62","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s40425-019-0784-9","article-title":"EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma","volume":"7","author":"Xiao","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2022.106333_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001889","article-title":"Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis","volume":"9","author":"Bottcher","year":"2021","journal-title":"J. Immunother. Cancer"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182200278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182200278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:40:31Z","timestamp":1760913631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182200278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"alternative-id":["S104366182200278X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106333","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106333"}}